1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 CAR-T 1.2.3 TCR-T 1.2.4 NK 1.2.5 TIL 1.3 Market by Application 1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Lymphoma 1.3.3 Leukemia 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Adoptive Cell Therapy Market Perspective (2016-2027) 2.2 Adoptive Cell Therapy Growth Trends by Regions 2.2.1 Adoptive Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Adoptive Cell Therapy Industry Dynamic 2.3.1 Adoptive Cell Therapy Market Trends 2.3.2 Adoptive Cell Therapy Market Drivers 2.3.3 Adoptive Cell Therapy Market Challenges 2.3.4 Adoptive Cell Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Adoptive Cell Therapy Players by Revenue 3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2016-2021) 3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue 3.4 Global Adoptive Cell Therapy Market Concentration Ratio 3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2020 3.5 Adoptive Cell Therapy Key Players Head office and Area Served 3.6 Key Players Adoptive Cell Therapy Product Solution and Service 3.7 Date of Enter into Adoptive Cell Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Adoptive Cell Therapy Breakdown Data by Type 4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2016-2021) 4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027) 5 Adoptive Cell Therapy Breakdown Data by Application 5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2016-2021) 5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Adoptive Cell Therapy Market Size (2016-2027) 6.2 North America Adoptive Cell Therapy Market Size by Type 6.2.1 North America Adoptive Cell Therapy Market Size by Type (2016-2021) 6.2.2 North America Adoptive Cell Therapy Market Size by Type (2022-2027) 6.2.3 North America Adoptive Cell Therapy Market Size by Type (2016-2027) 6.3 North America Adoptive Cell Therapy Market Size by Application 6.3.1 North America Adoptive Cell Therapy Market Size by Application (2016-2021) 6.3.2 North America Adoptive Cell Therapy Market Size by Application (2022-2027) 6.3.3 North America Adoptive Cell Therapy Market Size by Application (2016-2027) 6.4 North America Adoptive Cell Therapy Market Size by Country 6.4.1 North America Adoptive Cell Therapy Market Size by Country (2016-2021) 6.4.2 North America Adoptive Cell Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Adoptive Cell Therapy Market Size (2016-2027) 7.2 Europe Adoptive Cell Therapy Market Size by Type 7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2016-2021) 7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2022-2027) 7.2.3 Europe Adoptive Cell Therapy Market Size by Type (2016-2027) 7.3 Europe Adoptive Cell Therapy Market Size by Application 7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2016-2021) 7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2022-2027) 7.3.3 Europe Adoptive Cell Therapy Market Size by Application (2016-2027) 7.4 Europe Adoptive Cell Therapy Market Size by Country 7.4.1 Europe Adoptive Cell Therapy Market Size by Country (2016-2021) 7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2016-2027) 8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type 8.2.1 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application 8.3.1 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region 8.4.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Adoptive Cell Therapy Market Size (2016-2027) 9.2 Latin America Adoptive Cell Therapy Market Size by Type 9.2.1 Latin America Adoptive Cell Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Adoptive Cell Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Adoptive Cell Therapy Market Size by Type (2016-2027) 9.3 Latin America Adoptive Cell Therapy Market Size by Application 9.3.1 Latin America Adoptive Cell Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Adoptive Cell Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Adoptive Cell Therapy Market Size by Application (2016-2027) 9.4 Latin America Adoptive Cell Therapy Market Size by Country 9.4.1 Latin America Adoptive Cell Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Adoptive Cell Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2016-2027) 10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type 10.2.1 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application 10.3.1 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country 10.4.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Adoptive Cell Therapy Introduction 11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 Juno 11.2.1 Juno Company Details 11.2.2 Juno Business Overview 11.2.3 Juno Adoptive Cell Therapy Introduction 11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2016-2021) 11.2.5 Juno Recent Development 11.3 Kite 11.3.1 Kite Company Details 11.3.2 Kite Business Overview 11.3.3 Kite Adoptive Cell Therapy Introduction 11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2016-2021) 11.3.5 Kite Recent Development 11.4 Adaptimmune 11.4.1 Adaptimmune Company Details 11.4.2 Adaptimmune Business Overview 11.4.3 Adaptimmune Adoptive Cell Therapy Introduction 11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021) 11.4.5 Adaptimmune Recent Development 11.5 Fibrocell 11.5.1 Fibrocell Company Details 11.5.2 Fibrocell Business Overview 11.5.3 Fibrocell Adoptive Cell Therapy Introduction 11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021) 11.5.5 Fibrocell Recent Development 11.6 Lineage Cell Therapeutics 11.6.1 Lineage Cell Therapeutics Company Details 11.6.2 Lineage Cell Therapeutics Business Overview 11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction 11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) 11.6.5 Lineage Cell Therapeutics Recent Development 11.7 BioTime 11.7.1 BioTime Company Details 11.7.2 BioTime Business Overview 11.7.3 BioTime Adoptive Cell Therapy Introduction 11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2016-2021) 11.7.5 BioTime Recent Development 11.8 Vericel Corporation 11.8.1 Vericel Corporation Company Details 11.8.2 Vericel Corporation Business Overview 11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction 11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021) 11.8.5 Vericel Corporation Recent Development 11.9 Regeneus 11.9.1 Regeneus Company Details 11.9.2 Regeneus Business Overview 11.9.3 Regeneus Adoptive Cell Therapy Introduction 11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021) 11.9.5 Regeneus Recent Development 11.10 Anhui Anke Biotechnology 11.10.1 Anhui Anke Biotechnology Company Details 11.10.2 Anhui Anke Biotechnology Business Overview 11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction 11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021) 11.10.5 Anhui Anke Biotechnology Recent Development 11.11 Cellectis 11.11.1 Cellectis Company Details 11.11.2 Cellectis Business Overview 11.11.3 Cellectis Adoptive Cell Therapy Introduction 11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021) 11.11.5 Cellectis Recent Development 11.12 NantKwest 11.12.1 NantKwest Company Details 11.12.2 NantKwest Business Overview 11.12.3 NantKwest Adoptive Cell Therapy Introduction 11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021) 11.12.5 NantKwest Recent Development 11.13 SorrentoTherapeutics 11.13.1 SorrentoTherapeutics Company Details 11.13.2 SorrentoTherapeutics Business Overview 11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction 11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) 11.13.5 SorrentoTherapeutics Recent Development 11.14 Bellicum 11.14.1 Bellicum Company Details 11.14.2 Bellicum Business Overview 11.14.3 Bellicum Adoptive Cell Therapy Introduction 11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021) 11.14.5 Bellicum Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of CAR-T Table 3. Key Players of TCR-T Table 4. Key Players of NK Table 5. Key Players of TIL Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Adoptive Cell Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Adoptive Cell Therapy Market Share by Regions (2016-2021) Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Adoptive Cell Therapy Market Share by Regions (2022-2027) Table 12. Adoptive Cell Therapy Market Trends Table 13. Adoptive Cell Therapy Market Drivers Table 14. Adoptive Cell Therapy Market Challenges Table 15. Adoptive Cell Therapy Market Restraints Table 16. Global Adoptive Cell Therapy Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Adoptive Cell Therapy Market Share by Players (2016-2021) Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020) Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Adoptive Cell Therapy Product Solution and Service Table 23. Date of Enter into Adoptive Cell Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021) Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Adoptive Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021) Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 34. North America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 36. North America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Adoptive Cell Therapy Product Table 66. Novartis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 67. Novartis Recent Development Table 68. Juno Company Details Table 69. Juno Business Overview Table 70. Juno Adoptive Cell Therapy Product Table 71. Juno Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 72. Juno Recent Development Table 73. Kite Company Details Table 74. Kite Business Overview Table 75. Kite Adoptive Cell Therapy Product Table 76. Kite Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 77. Kite Recent Development Table 78. Adaptimmune Company Details Table 79. Adaptimmune Business Overview Table 80. Adaptimmune Adoptive Cell Therapy Product Table 81. Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 82. Adaptimmune Recent Development Table 83. Fibrocell Company Details Table 84. Fibrocell Business Overview Table 85. Fibrocell Adoptive Cell Therapy Product Table 86. Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 87. Fibrocell Recent Development Table 88. Lineage Cell Therapeutics Company Details Table 89. Lineage Cell Therapeutics Business Overview Table 90. Lineage Cell Therapeutics Adoptive Cell Therapy Product Table 91. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 92. Lineage Cell Therapeutics Recent Development Table 93. BioTime Company Details Table 94. BioTime Business Overview Table 95. BioTime Adoptive Cell Therapy Product Table 96. BioTime Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 97. BioTime Recent Development Table 98. Vericel Corporation Company Details Table 99. Vericel Corporation Business Overview Table 100. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 101. Vericel Corporation Recent Development Table 102. Regeneus Company Details Table 103. Regeneus Business Overview Table 104. Regeneus Adoptive Cell Therapy Product Table 105. Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 106. Regeneus Recent Development Table 107. Anhui Anke Biotechnology Company Details Table 108. Anhui Anke Biotechnology Business Overview Table 109. Anhui Anke Biotechnology Adoptive Cell Therapy Product Table 110. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 111. Anhui Anke Biotechnology Recent Development Table 112. Cellectis Company Details Table 113. Cellectis Business Overview Table 114. Cellectis Adoptive Cell Therapy Product Table 115. Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 116. Cellectis Recent Development Table 117. NantKwest Company Details Table 118. NantKwest Business Overview Table 119. NantKwest Adoptive Cell Therapy Product Table 120. NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 121. NantKwest Recent Development Table 122. SorrentoTherapeutics Company Details Table 123. SorrentoTherapeutics Business Overview Table 124. SorrentoTherapeutics Adoptive Cell Therapy Product Table 125. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 126. SorrentoTherapeutics Recent Development Table 127. Bellicum Company Details Table 128. Bellicum Business Overview Table 129. Bellicum Adoptive Cell Therapy Product Table 130. Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million) Table 131. Bellicum Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2027 Figure 2. CAR-T Features Figure 3. TCR-T Features Figure 4. NK Features Figure 5. TIL Features Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2027 Figure 7. Lymphoma Case Studies Figure 8. Leukemia Case Studies Figure 9. Adoptive Cell Therapy Report Years Considered Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Adoptive Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2027 Figure 13. Global Adoptive Cell Therapy Market Share by Regions (2022-2027) Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2020 Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2020 Figure 17. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021) Figure 18. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027) Figure 19. North America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Adoptive Cell Therapy Market Share by Type (2016-2027) Figure 21. North America Adoptive Cell Therapy Market Share by Application (2016-2027) Figure 22. North America Adoptive Cell Therapy Market Share by Country (2016-2027) Figure 23. United States Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Adoptive Cell Therapy Market Share by Type (2016-2027) Figure 27. Europe Adoptive Cell Therapy Market Share by Application (2016-2027) Figure 28. Europe Adoptive Cell Therapy Market Share by Country (2016-2027) Figure 29. Germany Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Adoptive Cell Therapy Market Share by Type (2016-2027) Figure 37. Asia-Pacific Adoptive Cell Therapy Market Share by Application (2016-2027) Figure 38. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2016-2027) Figure 39. China Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Adoptive Cell Therapy Market Share by Type (2016-2027) Figure 47. Latin America Adoptive Cell Therapy Market Share by Application (2016-2027) Figure 48. Latin America Adoptive Cell Therapy Market Share by Country (2016-2027) Figure 49. Mexico Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Adoptive Cell Therapy Market Share by Type (2016-2027) Figure 53. Middle East & Africa Adoptive Cell Therapy Market Share by Application (2016-2027) Figure 54. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2016-2027) Figure 55. Turkey Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 59. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 60. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 61. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 62. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 63. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 64. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 65. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 66. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 67. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 68. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 69. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 70. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 71. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed